Published in Br J Clin Pharmacol on February 01, 1982
Ergotamine abuse and extra-hepatic portal hypertension. Postgrad Med J (1985) 0.75
CLINICAL TRIAL OF INHALED ERGOTAMINE TARTRATE IN MIGRAINE. Br Med J (1964) 2.34
A new technique for recording compliance of human hand veins. Br J Clin Pharmacol (1981) 1.80
The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: methodological aspects and time effect curve. Acta Pharmacol Toxicol (Copenh) (1980) 0.95
Plethysmographic comparison of sublingual and intramuscular ergotamine. Clin Pharmacol Ther (1981) 0.93
Buccal absorption of ergotamine. J Neurol Neurosurg Psychiatry (1974) 0.87
Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia (2008) 1.83
The effects of caffeine and theophylline on nociceptive stimulation in the rat. Acta Pharmacol Toxicol (Copenh) (1973) 1.56
Morphine kinetics in children. Clin Pharmacol Ther (1979) 1.43
Determination of the luminal diameter of the radial artery in man by high frequency ultrasound: a methodological study. Ultrasound Med Biol (1990) 1.41
Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain (1989) 1.31
Morphine kinetics in cancer patients. Clin Pharmacol Ther (1981) 1.12
Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine. Clin Pharmacokinet (1982) 1.11
Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine. Cephalalgia (1989) 1.08
Prevalence and significance of muscle tenderness during common migraine attacks. Headache (1981) 1.04
Quantitative determination of morphine in biological samples by gas-liquid chromatography and electron-capture detection. J Pharm Pharmacol (1975) 1.02
Guidelines for controlled trials of drugs in tension-type headache: second edition. Cephalalgia (2010) 1.00
Pharmacodynamic and pharmacokinetic interactions between ketamine and diazepam. Eur J Clin Pharmacol (1983) 1.00
The blood-brain barrier in migraine treatment. Cephalalgia (2008) 0.99
Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials. Cephalalgia (1999) 0.99
Analgesia produced by clonidine in mice and rats. J Pharm Pharmacol (1974) 0.99
Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.99
Invasive adenoma of the pituitary gland and chronic migrainous neuralgia. A rare coincidence or a causal relationship? Cephalalgia (1982) 0.98
Comparison of rizatriptan and sumatriptan: a reply to O'Quinn et al. Headache (1999) 0.98
Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients. Br J Clin Pharmacol (1978) 0.96
The effect of ergotamine on the arterial system in man. Acta Pharmacol Toxicol (Copenh) (1986) 0.96
The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: methodological aspects and time effect curve. Acta Pharmacol Toxicol (Copenh) (1980) 0.95
The common migraine attack may not be initiated by cerebral ischaemia. Lancet (1981) 0.94
Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Demonstration of a therapeutic window in man. Eur J Clin Pharmacol (1984) 0.93
Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's disease. Acta Neurol Scand (1998) 0.92
Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status. Eur J Clin Pharmacol (1983) 0.92
Arterial responses during migraine headache. Lancet (1990) 0.92
Spreading cerebral oligemia in classical- and normal cerebral blood flow in common migraine. Headache (1982) 0.91
Guidelines for controlled trials of drugs in cluster headache. Cephalalgia (1995) 0.90
A double blind study of metoclopramide in the treatment of migraine attacks. J Neurol Neurosurg Psychiatry (1980) 0.90
Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam. Br J Clin Pharmacol (1988) 0.88
Keratoconus as a possible side-effect of acitretin (neotigason) therapy. Acta Derm Venereol (1993) 0.88
Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats. J Pharmacol Exp Ther (1993) 0.88
Potential pulmonary uptake and clearance of morphine in postoperative patients. Eur J Clin Pharmacol (1986) 0.88
The headache-inducing effect of cilostazol in human volunteers. Cephalalgia (2006) 0.87
Treatment-emergent CNS symptoms following triptan therapy are part of the attack. Cephalalgia (2007) 0.87
Reduced contralateral hemispheric flow measured by SPECT in cerebellar lesions: crossed cerebral diaschisis. Acta Neurol Scand (1993) 0.86
Intramuscular ergotamine: plasma levels and dynamic activity. Clin Pharmacol Ther (1985) 0.86
Classic migraine. A prospective recording of symptoms. Acta Neurol Scand (1986) 0.85
Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients. J Headache Pain (2008) 0.85
Pharmacological treatment of cancer pain with special reference to the oral use of morphine. Acta Anaesthesiol Scand Suppl (1982) 0.85
Pharmacokinetics of methysergide and its metabolite methylergometrine in man. Eur J Clin Pharmacol (1986) 0.85
Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity. J Med Chem (1981) 0.84
Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia (1984) 0.84
Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate. Eur J Clin Pharmacol (1992) 0.84
The effect of ergotamine and dihydroergotamine on cerebral blood flow in man. Stroke (1987) 0.83
Morphine pharmacokinetics: GLC assay versus radioimmunoassay. J Pharm Sci (1982) 0.83
Paracetamol (acetaminophen) versus acetylsalicylic acid in migraine. Eur Neurol (1980) 0.81
Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design. Cephalalgia (2000) 0.81
Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand (1984) 0.81
Intraduodenal infusion of a water-based levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's disease. Eur J Clin Pharmacol (1993) 0.81
Interictal "patchy" regional cerebral blood flow patterns in migraine patients. A single photon emission computerized tomographic study. Eur J Neurol (1994) 0.80
Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs. J Neurol (1991) 0.80
Prophylactic pharmacotherapy of migraine. Some practical guidelines. Neurol Clin (1997) 0.80
A comparison of epidural morphine and epidural bupivacaine for postoperative pain relief. Acta Anaesthesiol Scand (1981) 0.80
Low biological availability of ergotamine tartrate after oral dosing in cluster headache. Cephalalgia (1981) 0.80
Pharmacokinetics and effects of levodopa in advanced Parkinson's disease. Eur J Clin Pharmacol (1990) 0.80
A comment on time-to-event analysis for headache relief. Cephalalgia (2000) 0.80
Efficacy of beta-blockers in migraine. A critical review. Cephalalgia (1986) 0.80
Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers. Eur J Clin Pharmacol (1982) 0.79
Pharmacokinetics of theophylline in young children with asthma: comparison of rectal enema and suppositories. Eur J Clin Pharmacol (1979) 0.79
Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine. Neurology (2001) 0.79
Antinociceptive action of oxotremorine and regional turnover of rat brain noradrenaline, dopamine and 5-HT. Eur J Pharmacol (1975) 0.79
Malnutrition and pharmacokinetics of penicillin in Ethiopian children. Pharmacol Toxicol (1995) 0.79
CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine. Cephalalgia (2010) 0.79
Methodological aspects of drug trials in migraine. Neuroepidemiology (1985) 0.79
Pharmacokinetics of levodopa and carbidopa in rats following different routes of administration. Pharm Res (1994) 0.79
Dose-response curve for the ergotamine-induced decrease of peripheral systolic blood pressure in man. Acta Pharmacol Toxicol (Copenh) (1984) 0.78
Arterial response to ergotamine tartrate in abusing and non-abusing migraine patients. Acta Pharmacol Toxicol (Copenh) (1981) 0.78
Comparison of pharmacodynamic effects and plasma levels of oral and rectal ergotamine. Cephalalgia (1986) 0.78
An electrical method for estimation of analgesic activity in mice. II. Application of the method in investigations of some analgesic drugs. Acta Pharm Suec (1969) 0.78
Nitroglycerin provocation in normal subjects is not a useful human migraine model? Cephalalgia (2010) 0.78
Lignocaine versus saline in migraine pain. Lancet (1980) 0.78
Lack of tolerance of headache and radial artery diameter during a 7 hour intravenous infusion of nitroglycerin. Eur J Clin Pharmacol (1993) 0.78
Duration of the biological effect of ergotamine tartrate. Adv Neurol (1982) 0.78
The analgesic properties of methylsalicylic acids. Acta Pharm Suec (1970) 0.78
Finding new drug targets for the treatment of migraine attacks. Cephalalgia (2009) 0.78
Clonidine kinetics in man--evidence for dose dependency and changed pharmacokinetics during chronic therapy. Br J Clin Pharmacol (1981) 0.78
Clinical trial of nimodipine for single attacks of classic migraine. Cephalalgia (1985) 0.78
Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice. Cephalalgia (1995) 0.78
Theophylline increased sensitivity to nociceptive stimulation and regional turnover of rat brain 5-HT, noradrenaline and dopamine. Acta Pharmacol Toxicol (Copenh) (1974) 0.77
Interaction of mixed micelles formed from glycocholic acid and lecithin with the protein binding of various drugs. Br J Clin Pharmacol (1987) 0.77
Blood and brain concentration of morphine and its relation to the analgesic activity in mice. Acta Pharm Suec (1971) 0.77
Enhancement of apomorphine-induced inhibition of vocalisation afterdischarge response by theophylline. Life Sci (1975) 0.77
Decreased chloramphenicol clearance in malnourished Ethiopian children. Eur J Clin Pharmacol (1993) 0.77
Small arteries can be accurately studied in vivo, using high frequency ultrasound. Ultrasound Med Biol (1993) 0.77
Simultaneous determination of codeine and morphine in biological samples by gas chromatography with electron capture detection. Acta Pharmacol Toxicol (Copenh) (1977) 0.77
Lithium absorption from ordinary and from sustained-release tablets. Acta Pharm Suec (1972) 0.77
Relationship between clonidine kinetics and its blood pressure effects. Acta Med Scand Suppl (1979) 0.77
Abrupt and gradual change from clonidine to beta blockers in hypertension. Acta Med Scand (1982) 0.77
Plasma clonidine in relation to blood pressure, catecholamines, and renin activity during long-term treatment of hypertension. Clin Pharmacol Ther (1982) 0.77
The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial. Cephalalgia (2001) 0.77
Probenecid-induced accumulation of 5-hydroxyindoleacetic acid and homovanillic acid in rat brain. J Pharm Pharmacol (1987) 0.77
INH and streptomycin in Ethiopian children with tuberculosis and different nutritional status. Acta Paediatr Scand (1988) 0.77
Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate. J Headache Pain (2008) 0.77
Nitroglycerin for ergotism. Experimental studies in vitro and in migraine patients and treatment of an overt case. Eur J Clin Pharmacol (1982) 0.76